Advertisement
Fear of discrimination is a major reason why about one-third of lesbian

Fear of Discrimination Keeps Many LGBT Med Students Silent

0
Thirty percent of LGBT surveyed said they didn't reveal sexual identity in medical school
Although people around the world are eating more healthy foods

Unhealthy Outpacing Healthy Eating in Most World Regions

0
The United States has one of the lowest-quality diets in the world
New research helps explain why getting too little sleep might boost diabetes risk. The study was published online Feb. 19 in Diabetologia.

Lack of Sleep Tied to Increased Levels of Free Fatty Acids

0
Findings may help explain why getting too little sleep might boost diabetes risk
Apology laws

Article Emphasizes Importance of Apology in Medical Error

0
Apology laws unnecessary if physicians understand the importance of offering accountability
A simple high-fiber diet can provide health benefits while being easier to stick with than a diet calling for multiple changes in eating habits

Increasing Dietary Fiber Leads to Other Healthy Changes

0
Trial comparing simple dietary change to more complicated regimen found similar health benefits
Many adults maintain adequate serum 25-hydroxyvitamin D levels even in periods of minimal ultraviolet radiation exposure

Many Adults Maintain Adequate Vitamin D With Minimal UVR

0
Review shows adequate serum vitamin D levels despite negligible ultraviolet radiation exposure
For Japanese men with visceral fat accumulation and hemoglobin A1C of 5.6 to 6.4 percent

At Least 4 to 5 Percent Weight Loss Needed to Cut Diabetes Risk

0
Findings in Japanese men with visceral fat accumulation, hemoglobin A1C of 5.6 to 6.4 percent
In an environment where patients are increasingly aware of the costs of health care

High Deductible Plans Factor Into Physician-Patient Relationship

0
Physicians may want to be proactive by detailing costs and options for patients
The kinase inhibitor Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy

FDA Approves Lenvima for Type of Thyroid Cancer

0
To treat differentiated thyroid cancer that has progressed despite radioactive iodine therapy
Women and men below age 70 who are treated for osteoporosis have an excess mortality risk

Osteoporosis-Treated Adults Have Elevated Risk of Mortality

0
Residual life expectancy for 50- and 75-year-old man starting treatment estimated at 18.2 and 7.5 years